Description
ML339 is a potent and selective CXCR6 ( IC 50 of 140 nM) antagonist that is selective (IC 50 >79 µM) against CXCR5, CXCR4, CCR6 and Apelin receptor (APJ). ML339 holds potential to advance the field of prostate cancer researchIC50& Target:CXCR6 140 nM (IC 50 )